V

VYNE Therapeutics

72 employees

VYNE Therapeutics is a clinical late-stage biopharmaceutical company developing treatments associated with dermatologic conditions.

Basic info

Industry

pharmaceuticals

Sectors

Atopic Dermatitis
Psoriasis
Dermatology
Acne
Topical
Pharmaceutical
Wound
Health Care
Foam
Formulation
Therapeutics
Skin
Rosacea

Date founded

2003

Funding rounds raised

Total raised

$51M

from 11 investors over 11 rounds

V

VYNE Therapeutics raised $51M on July 18, 2017

Investors: Aisling Capital, venBio Partners, F-Prime Capital Partners, Bay City Capital, Vivo Capital, Novo Holdings and Presidio Partners

V

VYNE Therapeutics raised $45M on November 1, 2015

Investors: Presidio Partners, Vivo Capital and F-Prime Capital Partners

V

VYNE Therapeutics raised $14M on May 1, 2015

Investors: CMEA Capital

FAQ